Papp, Zoltán

Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation

Kolijn, D., Pabel, S., Tian, Y., Lódi, M., Herwig, M., Carrizzo, A., Zhazykbayeva, S., Kovács, Á., Fülöp, G. Á., Falcão-Pires, I., et al. (2021) · Cardiovascular Research

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 323

The effect of myosin light chain 2 dephosphorylation on Ca-sensitivity of force is enhanced in failing human hearts

VANDERVELDEN, J., PAPP, Z., BOONTJE, N., ZAREMBA, R., DEJONG, J., JANSSEN, P., HASENFUSS, G., & STIENEN, G. (2003) · Cardiovascular Research

Cardiomyopathy and Myosin StudiesCardiovascular Function and Risk Factors

Cited by 147